The data illustrates the share of clinical trials investigating cannabis in the U.S. as of 2016, broken down by therapy area. Mental disorders was the therapy area with the highest share of clinical trials.
Mental disorders | 59 |
Substance-related disorders (drug abuse) | 43 |
Pain | 13 |
Neurodegenerative diseases | 5 |
Post Traumatic Stress Disorder (PTSD) | 5 |
Epilepsy | 4 |
Lung diseases | 3 |
Autoimmune disease | 3 |
Inflammatory bowel diseases | 2 |